Alpha power decreases with age during isoflurane anesthesia by Hight, Darren et al.
Alpha power decreases with age 
during isoflurane anesthesia
Hight, D.,1 Stucki, M.,1 Krejci, V.,1 Lersch, F.,1  Hartwich, V.,1 Rummel, C.,1 2 & Kaiser, H.1
1. University Hospital of Bern (Inselspital), Bern, Switzerland, 2. University Institute for Diagnostic and Interventional Neuroradiology, University Hospital Bern (Inselspital), Bern, Switzerland.
Conclusion:
Alpha power decreases with age during dependent isoflurane anesthesia,
and the alpha-age relationship is not on sampling strategies.
Introduction:
Alpha power (8 – 12 Hz) in the frontal electroencephalogram (EEG)
during general anesthesia is thought to originate from thalamocortical
oscillations, and decreases with increasing age (1). To date, this
relationship has not been examined during isoflurane anesthesia. It is
also unclear to what degree alpha power loss with ageing is
dependent on the anesthetic concentration at the time point of
sampling, as this factor has been reported, but not controlled for.
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Methods:
We analyzed preliminary data from 987 patients undergoing isoflurane
anesthesia for cardiac surgery (EPOCAS study (NCT02976584)). In
Matlab® (R2016a) initial spectra were calculated from two-second
(non-overlapping) artefact and burst-suppression free sections of pre-
bypass frontal EEG using the Fast Fourier Transform (‘spectrogram.m’).
Alpha power was the mean of the alpha range. Three sampling
strategies were tested: (i) non-bounded, where all spectra were
included in the final patient mean spectrum, (ii) VGA (Volatile Gas
Anesthetic) bounded, where only spectra where the VGA
concentration was within a ± 0.1 % isoflurane range were included,
and (iii) CeMAC-bounded, where only spectra where the age-adjusted
effect-site estimated (Ce) MAC (Minimal Alveolar Concentration) was
within a ± 0.1 CeMAC range around the median were included in each
final patient spectrum. We used an end-tidal to brain diffusion model
with a half-life of 144 seconds to estimate effect-site anesthetic
concentrations (MAC) which were then age-adjusted according to
Mapleson (2).
Figure 1: Relationship between Age (in years) and Alpha
Power (in decibels, dB) for three sampling strategies: (A)
unbounded, (B) sampling bound to volatile gas
anesthetic (VGA) isoflurane values between 0.7 and 0.9
%, and (D) sampling bound to effect-site age adjusted
MAC values between 0.67 and 0.87 MAC. Section (C)
shows a histogram of patient ages for all three sampling
strategies.
Median VGA
concentration was 0.8 %
isoflurane (IQR: 0.3 %),
and median age-adjusted
effect-site MAC was 0.77
(IQR: 0.24). Alpha power
decreased with increasing
age in the unbounded (R
= - 0.58, R2 = 0.34, p <
0.001) and in both
bounded sampling
strategies (VGA-bounded:
R = - 0.60, R2 = 0.36, p <
0.001; CeMAC-bounded: R
= - 0.59, R2 = 0.35, p <
0.001), as shown in Figure
1. The strength of these
associations are similar to
previously published
values for both propofol
(R = - 0.65, R2 = 0.43, p <
0.01) and sevoflurane (R =
- 0.68, R2 = 0.46, p < 0.01)
(2). In the two bounded
sampling strategies, 222 and 130 patients (in the VGA- and CeMAC-
bounded groups respectively) did not have EEG sections fitting the
restricted criteria, and fell out of the analysis, but the median age was the
same for all strategies.
Results: In all patients, median patient age was 67 years (Inter-quartile 
range (IQR): 15). 
